Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after

Shu-qin Ying1, Mei-xiang Xiang, Lu Fang

  • 1Department of Cardiology, the Second Affiliated Hospital, Zhejiang University, Hangzhou, China.

Insights

Percutaneous coronary intervention (PCI) alters P-selectin and magnesium levels, impacting restenosis and heart injury. Early P-selectin elevation and low magnesium post-PCI correlate with adverse events, suggesting therapeutic targets.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biochemistry

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Restenosis and ischemia-reperfusion injury remain significant complications after PCI.
  • Understanding the molecular mechanisms is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the mechanisms of restenosis and myocardial ischemia-reperfusion injury following PCI.
  • To assess the temporal changes in specific biomarkers associated with PCI complications.
  • To identify potential therapeutic targets for mitigating adverse events.

Main Methods:

  • Serial measurements of P-selectin, plasminogen activator inhibitor-1 (PAI-1), magnesium (Mg), and creatine kinase-myocardial band fraction (CK-MB) were performed post-PCI.
  • Correlations between biomarker levels and PCI procedural parameters were analyzed.
  • Six-month follow-up data on major adverse cardiovascular events were collected.

Main Results:

  • PCI led to early P-selectin elevation, correlated with inflation pressure.
  • A significant, sustained decrease in serum Mg was observed post-PCI.
  • Elevated P-selectin and decreased Mg were associated with recurrent treatment and heart failure, respectively.
  • CK-MB levels increased but remained within normal ranges; PAI-1 levels were unaffected.

Conclusions:

  • PCI induces dynamic changes in P-selectin, Mg, and CK-MB, implicated in restenosis and myocardial injury.
  • Early detection of altered P-selectin and Mg levels may predict adverse cardiovascular events.
  • Antiplatelet therapy and magnesium supplementation are potential strategies to reduce PCI-related risks.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...